Takeuchi M, Higaki A, Kojima Y, Ono K, Maruhisa T, Yokoyama T
Jpn J Radiol. 2024; .
PMID: 39548050
DOI: 10.1007/s11604-024-01694-1.
James N, Pirrie S, Liu W, Catto J, Jefferson K, Patel P
Health Technol Assess. 2024; 28(42):1-65.
PMID: 39246267
PMC: 11403381.
DOI: 10.3310/DEHT5407.
Takeuchi M, Tamada T, Higaki A, Kojima Y, Ueno Y, Yamamoto A
Abdom Radiol (NY). 2024; 49(12):4463-4480.
PMID: 38900320
DOI: 10.1007/s00261-024-04424-3.
Akin O, Lema-Dopico A, Paudyal R, Konar A, Chenevert T, Malyarenko D
Cancers (Basel). 2023; 15(22).
PMID: 38001728
PMC: 10670574.
DOI: 10.3390/cancers15225468.
Chen G, Fan X, Wang T, Zhang E, Shao J, Chen S
Eur Radiol. 2023; 33(12):8821-8832.
PMID: 37470826
DOI: 10.1007/s00330-023-09960-y.
Image quality evaluation of diffusion-weighted imaging in bladder cancer: a comparison between integrated slice-specific dynamic shimming and single-shot echo-planar imaging.
Wang Y, Chen S, Zhang W, Xiao W, Su J, Zhang R
Quant Imaging Med Surg. 2023; 13(4):2526-2537.
PMID: 37064386
PMC: 10102749.
DOI: 10.21037/qims-22-851.
Application of Vesical Imaging-Reporting and Data System in Evaluation of Urinary Bladder Cancer Using Multiparametric Magnetic Resonance Imaging: A Hospital-Based Cross-Sectional Study.
Gupta R, Mahajan M, Sharma P, Bhardwaj S, Gupta V, Mahajan A
Avicenna J Med. 2022; 12(4):162-168.
PMID: 36570433
PMC: 9771629.
DOI: 10.1055/s-0042-1755334.
The comparison between contrast-enhanced ultrasound and contrast-enhanced magnetic resonance imaging in diagnosing bladder urothelial carcinoma.
Fu W, Liu D, Xiong Y, Liu C, Liu J, Yi X
Int Urol Nephrol. 2022; 55(5):1073-1079.
PMID: 36422743
DOI: 10.1007/s11255-022-03410-2.
Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer.
Shalaby E, Mohamed A, Elkammash T, Abouelkheir R, Housseini A
Curr Urol. 2022; 16(3):127-135.
PMID: 36204360
PMC: 9527936.
DOI: 10.1097/CU9.0000000000000128.
VI-RADS score system - A primer for urologists.
Nicola R, Pecoraro M, Lucciola S, Dos Reis R, Narumi Y, Panebianco V
Int Braz J Urol. 2022; 48(4):609-622.
PMID: 35195385
PMC: 9306377.
DOI: 10.1590/S1677-5538.IBJU.2021.0560.
Imaging of Bladder Cancer: Standard Applications and Future Trends.
Abouelkheir R, Abdelhamid A, Abou El-Ghar M, El-Diasty T
Medicina (Kaunas). 2021; 57(3).
PMID: 33804350
PMC: 8000909.
DOI: 10.3390/medicina57030220.
Role of magnetic resonance imaging in tumor staging and follow-up for bladder cancer.
Sim K, Sung D
Transl Androl Urol. 2021; 9(6):2890-2907.
PMID: 33457263
PMC: 7807353.
DOI: 10.21037/tau-19-671.
Diagnostic Accuracy of Multi-Parametric Magnetic Resonance Imaging for Tumor Staging of Bladder Cancer: Meta-Analysis.
Zhang N, Wang X, Wang C, Chen S, Wu J, Zhang G
Front Oncol. 2019; 9:981.
PMID: 31637213
PMC: 6788297.
DOI: 10.3389/fonc.2019.00981.
Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
Makboul M, Farghaly S, Abdelkawi I
Br J Radiol. 2019; 92(1104):20190401.
PMID: 31573328
PMC: 6913364.
DOI: 10.1259/bjr.20190401.
Identifying non-muscle-invasive and muscle-invasive bladder cancer based on blood serum surface-enhanced Raman spectroscopy.
Chen S, Zhu S, Cui X, Xu W, Kong C, Zhang Z
Biomed Opt Express. 2019; 10(7):3533-3544.
PMID: 31467792
PMC: 6706043.
DOI: 10.1364/BOE.10.003533.
Diffusion-weighted magnetic resonance imaging in bladder cancer: comparison of readout-segmented and single-shot EPI techniques.
Chen H, Chen L, Liu F, Lu J, Xu C, Wang L
Cancer Imaging. 2019; 19(1):59.
PMID: 31455403
PMC: 6712649.
DOI: 10.1186/s40644-019-0245-1.
Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
Wang F, Chen H, Zhang R, Jin D, Xu S, Wu G
Eur Radiol. 2019; 29(8):4447-4455.
PMID: 30666451
DOI: 10.1007/s00330-018-5977-y.
Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).
Panebianco V, Narumi Y, Altun E, Bochner B, Efstathiou J, Hafeez S
Eur Urol. 2018; 74(3):294-306.
PMID: 29755006
PMC: 6690492.
DOI: 10.1016/j.eururo.2018.04.029.
Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI.
Li H, Liu L, Shi Q, Stemmer A, Zeng H, Li Y
Medicine (Baltimore). 2018; 96(50):e9292.
PMID: 29390388
PMC: 5815800.
DOI: 10.1097/MD.0000000000009292.
Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
Lee M, Shin S, Oh Y, Jung D, Cho N, Choi Y
Eur Radiol. 2017; 27(9):3752-3758.
PMID: 28168374
DOI: 10.1007/s00330-017-4759-2.